BioLife Solutions, Inc. (BLFS) financial statements (2020 and earlier)

Company profile

Business Address 3303 MONTE VILLA PARKWAY
BOTHELL, WA 98021
State of Incorp. DE
Fiscal Year End December 31
SIC 3845 - Electromedical and Electrotherapeutic Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 31714100
Cash and cash equivalents 3171230
Short-term investments    27 
Receivables 311111
Inventory, net of allowances, customer advances and progress billings 422210
Inventory 422210
Other undisclosed current assets 000000
Total current assets: 381057122
Noncurrent Assets
Property, plant and equipment 111121
Long-term investments and receivables 7     
Long-term investments 7     
Intangible assets, net (including goodwill)    22
Intangible assets, net (excluding goodwill)    22 
Regulated entity, other noncurrent assets    00 
Deposits noncurrent assets 000000
Deferred costs      0
Other undisclosed noncurrent assets  122(0) 
Total noncurrent assets: 823541
TOTAL ASSETS: 4512812163
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 211212
Accounts payable 111101
Accrued liabilities 000000
Employee-related liabilities 100011
Deferred rent credit 0
Deferred revenue and credits00 11
Other undisclosed current liabilities    0(1)(1)
Total current liabilities: 221212
Noncurrent Liabilities
Liabilities, other than long-term debt 00    
Deferred rent credit 0
Other liabilities 00    
Other undisclosed noncurrent liabilities  041115
Total noncurrent liabilities: 0141115
Total liabilities: 2253217
Stockholders' equity
Stockholders' equity attributable to parent, including: 431031012(13)
Preferred stock  0    
Common stock 000000
Additional paid in capital 1148474737244
Accumulated deficit (71)(74)(71)(64)(60)(57)
Other undisclosed stockholders' equity attributable to parent    1(0) 
Stockholders' equity attributable to noncontrolling interest     2 
Other undisclosed stockholders' equity    (1)  
Total stockholders' equity: 43103914(13)
Other undisclosed liabilities and equity    1  
TOTAL LIABILITIES AND EQUITY: 4512812163

Income statement (P&L) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues 20118669
Revenue, net118669
Cost of revenue
(Cost of Goods and Services Sold)
 (6)(4)(3)(3)(3)(5)
Gross profit: 1475434
Operating expenses (10)(8)(10)(9)(6)(4)
Operating income (loss): 4(1)(5)(5)(3)(0)
Nonoperating income (expense) (0)(1)(3)0(0)(1)
Investment income, nonoperating   (3)   
Interest and debt expense (0)(0)(0) (0)(1)
Income (loss) from continuing operations before equity method investments, income taxes: 3(3)(8)(5)(3)(2)
Loss from equity method investments (1)     
Other undisclosed income from continuing operations before income taxes 1     
Income (loss) before gain (loss) on sale of properties: 3(3)(8)(5)(3)(2)
Other undisclosed net income  00 0 
Net income (loss): 3(3)(8)(5)(3)(2)
Net income attributable to noncontrolling interest   110 
Other undisclosed net income attributable to parent      1
Net income (loss) attributable to parent: 3(3)(7)(4)(3)(1)
Preferred stock dividends and other adjustments (0)(0)    
Net income (loss) available to common stockholders, diluted: 3(3)(7)(4)(3)(1)

Comprehensive Income ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net income (loss): 3(3)(8)(5)(3)(2)
Other comprehensive income (loss)   00(0) 
Other undisclosed comprehensive income    10 
Comprehensive income (loss): 3(3)(8)(4)(3)(2)
Comprehensive income, net of tax, attributable to noncontrolling interest   110 
Other undisclosed comprehensive loss, net of tax, attributable to parent    (2)(0) 
Comprehensive income (loss), net of tax, attributable to parent: 3(3)(7)(5)(3)(2)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: